Cargando…

C. elegans as a test system to study relevant compounds that contribute to the specific health-related effects of different cannabis varieties

BACKGROUND: The medicinal effects of cannabis varieties on the market cannot be explained solely by the presence of the major cannabinoids Δ(9)-tetrahydrocannabinol (THC) and cannabidiol (CBD). Evidence for putative entourage effects caused by other compounds present in cannabis is hard to obtain du...

Descripción completa

Detalles Bibliográficos
Autores principales: van Es-Remers, Monique, Spadaro, Jesus Arellano, Poppelaars, Eefje, Kim, Hye Kyong, van Haaster, Marieke, de Wit, Marcel, ILiopoulou, Eva, Wildwater, Marjolein, Korthout, Henrie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528106/
https://www.ncbi.nlm.nih.gov/pubmed/36184617
http://dx.doi.org/10.1186/s42238-022-00162-9
_version_ 1784801239589978112
author van Es-Remers, Monique
Spadaro, Jesus Arellano
Poppelaars, Eefje
Kim, Hye Kyong
van Haaster, Marieke
de Wit, Marcel
ILiopoulou, Eva
Wildwater, Marjolein
Korthout, Henrie
author_facet van Es-Remers, Monique
Spadaro, Jesus Arellano
Poppelaars, Eefje
Kim, Hye Kyong
van Haaster, Marieke
de Wit, Marcel
ILiopoulou, Eva
Wildwater, Marjolein
Korthout, Henrie
author_sort van Es-Remers, Monique
collection PubMed
description BACKGROUND: The medicinal effects of cannabis varieties on the market cannot be explained solely by the presence of the major cannabinoids Δ(9)-tetrahydrocannabinol (THC) and cannabidiol (CBD). Evidence for putative entourage effects caused by other compounds present in cannabis is hard to obtain due to the subjective nature of patient experience data. Caenorhabditis elegans (C. elegans) is an objective test system to identify cannabis compounds involved in claimed health and entourage effects. METHODS: From a medicinal cannabis breeding program by MariPharm BV, the Netherlands a set of 12 varieties were selected both THC rich varieties as well as CBD rich varieties. A consecutive extraction process was applied resulting in a non-polar (cannabinoid-rich) and polar (cannabinoid-poor) extract of each variety. The test model C. elegans was exposed to these extracts in a broad set of bioassays for appetite control, body oscillation, motility, and nervous system function. RESULTS: Exposing C. elegans to extracts with a high concentration of cannabinoids (> 1 μg/mL) reduces the life span of C. elegans dramatically. Exposing the nematodes to the low-cannabinoid (< 0.005 μg/mL) polar extracts, however, resulted in significant effects with respect to appetite control, body oscillation, motility, and nervous system-related functions in a dose-dependent and variety-dependent manner. DISCUSSION: C. elegans is a small, transparent organism with a complete nervous system, behavior and is due to its genetic robustness and short life cycle highly suitable to unravel entourage effects of Cannabis compounds. Although C. elegans lacks an obvious CB1 and CB2 receptor it has orthologs of Serotonin and Vanilloid receptor which are also involved in (endo)cannabinoid signaling. CONCLUSION: By using C. elegans, we were able to objectively distinguish different effects of different varieties despite the cannabinoid content. C. elegans seems a useful test system for studying entourage effects, for targeted medicinal cannabis breeding programs and product development. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s42238-022-00162-9.
format Online
Article
Text
id pubmed-9528106
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95281062022-10-04 C. elegans as a test system to study relevant compounds that contribute to the specific health-related effects of different cannabis varieties van Es-Remers, Monique Spadaro, Jesus Arellano Poppelaars, Eefje Kim, Hye Kyong van Haaster, Marieke de Wit, Marcel ILiopoulou, Eva Wildwater, Marjolein Korthout, Henrie J Cannabis Res Original Research BACKGROUND: The medicinal effects of cannabis varieties on the market cannot be explained solely by the presence of the major cannabinoids Δ(9)-tetrahydrocannabinol (THC) and cannabidiol (CBD). Evidence for putative entourage effects caused by other compounds present in cannabis is hard to obtain due to the subjective nature of patient experience data. Caenorhabditis elegans (C. elegans) is an objective test system to identify cannabis compounds involved in claimed health and entourage effects. METHODS: From a medicinal cannabis breeding program by MariPharm BV, the Netherlands a set of 12 varieties were selected both THC rich varieties as well as CBD rich varieties. A consecutive extraction process was applied resulting in a non-polar (cannabinoid-rich) and polar (cannabinoid-poor) extract of each variety. The test model C. elegans was exposed to these extracts in a broad set of bioassays for appetite control, body oscillation, motility, and nervous system function. RESULTS: Exposing C. elegans to extracts with a high concentration of cannabinoids (> 1 μg/mL) reduces the life span of C. elegans dramatically. Exposing the nematodes to the low-cannabinoid (< 0.005 μg/mL) polar extracts, however, resulted in significant effects with respect to appetite control, body oscillation, motility, and nervous system-related functions in a dose-dependent and variety-dependent manner. DISCUSSION: C. elegans is a small, transparent organism with a complete nervous system, behavior and is due to its genetic robustness and short life cycle highly suitable to unravel entourage effects of Cannabis compounds. Although C. elegans lacks an obvious CB1 and CB2 receptor it has orthologs of Serotonin and Vanilloid receptor which are also involved in (endo)cannabinoid signaling. CONCLUSION: By using C. elegans, we were able to objectively distinguish different effects of different varieties despite the cannabinoid content. C. elegans seems a useful test system for studying entourage effects, for targeted medicinal cannabis breeding programs and product development. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s42238-022-00162-9. BioMed Central 2022-10-03 /pmc/articles/PMC9528106/ /pubmed/36184617 http://dx.doi.org/10.1186/s42238-022-00162-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Research
van Es-Remers, Monique
Spadaro, Jesus Arellano
Poppelaars, Eefje
Kim, Hye Kyong
van Haaster, Marieke
de Wit, Marcel
ILiopoulou, Eva
Wildwater, Marjolein
Korthout, Henrie
C. elegans as a test system to study relevant compounds that contribute to the specific health-related effects of different cannabis varieties
title C. elegans as a test system to study relevant compounds that contribute to the specific health-related effects of different cannabis varieties
title_full C. elegans as a test system to study relevant compounds that contribute to the specific health-related effects of different cannabis varieties
title_fullStr C. elegans as a test system to study relevant compounds that contribute to the specific health-related effects of different cannabis varieties
title_full_unstemmed C. elegans as a test system to study relevant compounds that contribute to the specific health-related effects of different cannabis varieties
title_short C. elegans as a test system to study relevant compounds that contribute to the specific health-related effects of different cannabis varieties
title_sort c. elegans as a test system to study relevant compounds that contribute to the specific health-related effects of different cannabis varieties
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528106/
https://www.ncbi.nlm.nih.gov/pubmed/36184617
http://dx.doi.org/10.1186/s42238-022-00162-9
work_keys_str_mv AT vanesremersmonique celegansasatestsystemtostudyrelevantcompoundsthatcontributetothespecifichealthrelatedeffectsofdifferentcannabisvarieties
AT spadarojesusarellano celegansasatestsystemtostudyrelevantcompoundsthatcontributetothespecifichealthrelatedeffectsofdifferentcannabisvarieties
AT poppelaarseefje celegansasatestsystemtostudyrelevantcompoundsthatcontributetothespecifichealthrelatedeffectsofdifferentcannabisvarieties
AT kimhyekyong celegansasatestsystemtostudyrelevantcompoundsthatcontributetothespecifichealthrelatedeffectsofdifferentcannabisvarieties
AT vanhaastermarieke celegansasatestsystemtostudyrelevantcompoundsthatcontributetothespecifichealthrelatedeffectsofdifferentcannabisvarieties
AT dewitmarcel celegansasatestsystemtostudyrelevantcompoundsthatcontributetothespecifichealthrelatedeffectsofdifferentcannabisvarieties
AT iliopouloueva celegansasatestsystemtostudyrelevantcompoundsthatcontributetothespecifichealthrelatedeffectsofdifferentcannabisvarieties
AT wildwatermarjolein celegansasatestsystemtostudyrelevantcompoundsthatcontributetothespecifichealthrelatedeffectsofdifferentcannabisvarieties
AT korthouthenrie celegansasatestsystemtostudyrelevantcompoundsthatcontributetothespecifichealthrelatedeffectsofdifferentcannabisvarieties